The Limb Salvage Center

Filter Your Results




Study Presented at CIRSE Explores Ocular Radiation Exposure and Role of Protective Eyewear

September 22, 2017 -- Gerard Goh, MBBS, FRANZCR, EBIR, and colleagues presented data at CIRSE 2017, the annual congress of the Cardiovascular and Interventional Radiological S…

In-Stent Restenosis Treatment Indication Approved in Europe for Avinger's Pantheris Lumivascular Atherectomy System

September 26, 2017 -- Avinger, Inc. announced CE Mark approval for treating in-stent restenosis with the company's Pantheris Lumivascular atherectomy system. According …

iVascular's Luminor 14m DCB Approved in Canada

September 21, 2017 -- iVascular S.L.U. announced that it has received the Canadian Medical Device License for the company's paclitaxel-eluting Luminor 14m peripheral ballo…

DISRUPT BTK Results Reported for Shockwave Medical's Lithoplasty System

September 19, 2017 -- Shockwave Medical announced that results from the DISRUPT BTK study were presented at CIRSE 2017, the annual congress of the Cardiovascular and Intervent…

Twelve-Month Ranger DCB All-Comers Registry Data Presented at CIRSE

September 17, 2017 -- Twelve-month data from an all-comers registry evaluating the Ranger drug-coated balloon (DCB) for peripheral arterial use were presented by Michael K.W. …

Long-Term Data From Liberty 360° Show Positive Impact for Patients Receiving Endovascular Therapy

With Ehrin J. Armstrong, MD; Jihad A. Mustapha, MD; George A. Pliagas, MD; and Jason A. Yoho, MD

September 2017—A roundtable discussion of the real-world LIBERTY 360° 12-month data and the study’s significance in treating patients with peripheral artery disease and critical limb ischemia.

Surmodics' 0.014-Inch Low-Profile PTA Balloon Dilation Catheter Receives FDA Clearance and CE Mark Approval

September 18, 2017 -- Surmodics, Inc. announced that it has received US Food and Drug Administration 510(k) clearance and European CE Mark approval for its 0.014-inch low-prof…

Efficacy Data Presented for iVascular’s Luminor DCB

September 18, 2017 -- iVascular SLU announced that the efficacy of the company's Luminor drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD) was d…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.